TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 213 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 3.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $105,000 | -46.7% | 3,893 | -5.8% | 0.05% | -36.5% |
| Q4 2021 | $197,000 | +8.2% | 4,131 | +51.0% | 0.07% | -7.5% |
| Q3 2021 | $182,000 | -19.1% | 2,735 | -5.0% | 0.08% | -14.0% |
| Q2 2021 | $225,000 | +0.4% | 2,880 | +21.7% | 0.09% | -2.1% |
| Q1 2021 | $224,000 | -21.1% | 2,366 | +1.4% | 0.10% | -19.5% |
| Q4 2020 | $284,000 | -35.5% | 2,333 | -53.7% | 0.12% | -48.9% |
| Q3 2020 | $440,000 | +18.9% | 5,034 | -12.1% | 0.23% | +32.0% |
| Q2 2020 | $370,000 | +27.6% | 5,728 | -11.8% | 0.18% | +47.1% |
| Q1 2020 | $290,000 | -37.5% | 6,498 | -12.7% | 0.12% | +56.6% |
| Q4 2019 | $464,000 | – | 7,444 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |